Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Improving PTSD therapy outcomes for veterans

Official title: Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course

Run by United States Department of Defense · NCT06957067 · Data updated 2026-11-12

This study is testing whether two different ways of helping veterans with PTSD stick to their therapy can improve their treatment results.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment280 (estimated)
SponsorUnited States Department of Defense
Federal
Locations4 sites (Phoenix, Arizona and 3 other locations)
StatusRecruiting
StartedMarch 17, 2025
Main results expectedMay 31, 2028
Study endsAugust 31, 2028
Registry record updatedSeptember 11, 2026
Trial IDNCT06957067 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are veterans who meet DSM-5 criteria for PTSD and are interested in outpatient psychotherapy.

Probably not a fit

Patients with severe cognitive impairment or uncontrolled psychiatric symptoms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the effectiveness of Cognitive Processing Therapy (CPT) for veterans with Post Traumatic Stress Disorder (PTSD) by comparing two methods of identifying individuals who may struggle with the therapy. Investigators will assess whether using CPT skills or considering a switch to Present Centered Therapy (PCT) leads to better treatment retention and outcomes. The study will also explore barriers to implementing these intervention strategies and examine the stability of treatment differences over time. By utilizing behavioral and attitudinal measures, the research seeks to identify those in need of additional support during their therapy.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment outcomes and retention rates for veterans undergoing therapy for PTSD.

How similar studies have gone: Other studies have shown promise in improving PTSD treatment outcomes through tailored interventions, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Veterans interested in outpatient VA psychotherapy for PTSD
* Meets DSM-5 criteria for PTSD
* Be able to provide informed consent
* Be willing to be randomized
* Agree to not receive non-study psychotherapy for PTSD during study treatment (case management, supportive therapy/group, and concurrent substance use treatment are allowable)

Exclusion Criteria:

* Severe cognitive impairment
* Current suicidal or homicidal intent with a specific plan
* Uncontrolled psychotic or manic symptoms
* A psychiatric medication change in the past month
* A severe SUD as diagnosed by the DSM-5

Where it's running

  • VA Phoenix Health Care System
    Phoenix, Arizona, United States
    Recruiting
  • New Orleans VA Medical Center
    New Orleans, Louisiana, United States
    Recruiting
  • Ralph H. Johnson VA Health Care System (Charleston VA)
    Charleston, South Carolina, United States
    Recruiting
  • VA Houston Healthcare System
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Laura Meis, PhD — Women's Health Sciences Division of the National Center for PTSD; University of Minnesota
  • Study coordinator: Emily M Hudson, PhD
  • Email: emily.hudson@va.gov
  • Phone: 612-629-7262

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Anger, Social Thinking, and PTSD in French Veterans

    This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

    Recruiting Direction Centrale du Service de Santé des Armées · Draguignan · NCT07851090

  • TSND-201 treatment for PTSD in adults

    This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.

    Recruiting at 9 sites Phase 3 Transcend Therapeutics · Denver, Colorado and 8 other locations · NCT07836647

  • Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD

    This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.

    Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07732374

  • SEE FAR CBT for Adults With PTSD

    This 12-week, one-on-one SEE FAR CBT program tests a trauma-focused therapy to see if PTSD symptoms improve in adults 18 and older.

    Recruiting Community Stress Prevention Center · Kiryat Shmona · NCT07720674

  • Brief SEE FAR CBT: a short, focused therapy for adults with PTSD

    A 6-session Brief SEE FAR CBT treatment is tested against usual dynamic psychotherapy for adults with PTSD to see if it reduces symptoms.

    Recruiting Community Stress Prevention Center · Sha'ar Hanegev · NCT07710573

  • MDMA Therapy for PTSD in Veterans

    This phase 2 study tests a fixed 120 mg dose of MDMA, followed by a 60 mg supplemental dose, plus therapy, to see if it helps adults who are veterans with PTSD.

    Recruiting Phase 2 Sunstone Medical · Rockville, Maryland · NCT07569159

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.